Edinburgh Research Explorer

Dr Victoria Snowdon

(Former employee or visitor)

  1. 2017
  2. Serelaxin as a potential treatment for renal dysfunction in cirrhosis: Preclinical evaluation and results of a randomized phase 2 trial

    Snowdon, V. K., Lachlan, N. J., Hoy, A. M., Hadoke, P. W. F., Semple, S. I., Patel, D., Mungall, W., Kendall, T. J., Thomson, A., Lennen, R. J., Jansen, M. A., Moran, C. M., Pellicoro, A., Ramachandran, P., Shaw, I., Aucott, R. L., Severin, T., Saini, R., Pak, J., Yates, D. & 7 others, Dongre, N., Duffield, J. S., Webb, D. J., Iredale, J. P., Hayes, P. C., Fallowfield, J. A. & Taal, M. W. (ed.), 28 Feb 2017, In : PLOS Medicine. 14, 2, e1002248.

    Research output: Contribution to journalArticle

  3. 2016
  4. Editorial: measuring inflammatory and fibrotic components of portal hypertension - a noninvasive hepatic venous pressure gradient?

    Snowdon, V. K. & Fallowfield, J. A., Jul 2016, In : Alimentary Pharmacology and Therapeutics. 44, 2, p. 204-5 2 p.

    Research output: Contribution to journalEditorial

  5. 2014
  6. Relaxin Modulates Human and Rat Hepatic Myofibroblast Function and Ameliorates Portal Hypertension In Vivo

    Fallowfield, J., Hayden, A., Snowdon, V., Aucott, R., Stutchfield, B., Mole, D., Pellicoro, A., Gordon-Walker, T., Henke, A., Schrader, J., Trivedi, P., Princivalle, M., Forbes, S., Collins, J. & Iredale, J., Apr 2014, In : Hepatology. 59, 4, p. 1492–1504

    Research output: Contribution to journalArticle

  7. 2013
  8. Relaxin is a renal vasodilator in experimental models of cirrhosis and a potential novel therapy for hepatorenal syndrome in man

    Snowdon, V. K., Pellicoro, A., Ramachandran, P., Mungall, W., Jansen, M., Lennen, R., Aucott, R., Kendall, T., Hughes, J., Iredale, J. & Fallowfield, J., 27 Feb 2013, In : The Lancet. 381, Supplement 1, p. 102-102 1 p.

    Research output: Contribution to journalMeeting abstract

  9. 2012
  10. RELAXIN REDUCES PORTAL HYPERTENSION THROUGH STIMULATION OF HEPATIC NITRIC OXIDE PRODUCTION

    Fallowfield, J., Snowdon, V., Aucott, R., Gordon-Walker, T., Pellicoro, A. & Iredale, J., Jul 2012, In : Gut. 61, p. A125-A125 1 p.

    Research output: Contribution to journalMeeting abstract

  11. Differential Ly-6C expression identifies the recruited macrophage phenotype, which orchestrates the regression of murine liver fibrosis

    Ramachandran, P., Pellicoro, A., Vernon, M. A., Boulter, L., Aucott, R. L., Ali, A., Hartland, S. N., Snowdon, V. K., Cappon, A., Gordon-Walker, T. T., Williams, M. J., Dunbar, D. R., Manning, J., van Rooijen, N., Fallowfield, J. A., Forbes, S. J. & Iredale, J. P., 2012, In : Proceedings of the National Academy of Sciences. 109, 46, p. E3186-E3195

    Research output: Contribution to journalArticle

  12. Noninvasive evaluation of portal hypertension: emerging tools and techniques

    Snowdon, V. K., Guha, N. & Fallowfield, J. A., 2012, In : International journal of hepatology. 2012, p. 691089

    Research output: Contribution to journalArticle

Previous 1 2 Next